(19)
(11) EP 0 889 894 A1

(12)

(43) Date of publication:
13.01.1999 Bulletin 1999/02

(21) Application number: 97915161.0

(22) Date of filing: 18.03.1997
(51) International Patent Classification (IPC): 
A61K 31/ 00( . )
A61K 31/ 661( . )
A61K 31/ 664( . )
A61P 9/ 00( . )
A61P 9/ 12( . )
A61P 11/ 06( . )
A61P 13/ 12( . )
A61P 17/ 02( . )
A61P 29/ 00( . )
A61P 43/ 00( . )
C07F 9/ 44( . )
C07F 9/ 6512( . )
C07F 9/ 6539( . )
A61K 31/ 66( . )
A61K 31/ 6615( . )
A61P 1/ 00( . )
A61P 9/ 10( . )
A61P 11/ 00( . )
A61P 11/ 08( . )
A61P 15/ 00( . )
A61P 27/ 02( . )
A61P 37/ 06( . )
C07F 9/ 24( . )
C07F 9/ 6509( . )
C07F 9/ 653( . )
(86) International application number:
PCT/US1997/004364
(87) International publication number:
WO 1997/035864 (02.10.1997 Gazette 1997/42)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV RO SI

(30) Priority: 26.03.1996 US 19960624706

(71) Applicant: TEXAS BIOTECHNOLOGY CORPORATION
Houston, TX 77030 (US)

(72) Inventors:
  • CHAN, Ming, F.
    Encinitas, CA 92024 (US)
  • VERNER, Erik, J.
    Foster City, CA 94404 (US)

(74) Representative: Goldin, Douglas Michael, et al 
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) PHOSPHORAMIDATES AND PHOSPHINIC AMIDES, THEIR USE TO MODULATE THE ACTIVITY OF ENDOTHELIN